Heart remodeling and its prevention in patients with chronic heart failure due to coronary artery disease combined with chronic obstructive pulmonary disease

被引：0
|
作者：
Evdokimov, V. Vladimir [1 ]
Kovalenko, E. [1 ]
Zolotareva, E. [1 ]
Evdokimova, A. [1 ]
Voronina, G. [1 ]
Tebloev, K. [1 ]
机构：
[1] State Univ Med & Dent, Moscow, Russia
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1117
引用
收藏
页码：280 / 280
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of different types of bronchodilator therapy in patients with chronic heart failure due to coronary artery disease combined with chronic obstructive pulmonary disease
    Evdokimov, V.
    Evdokimova, A.
    Tebloev, K.
    Kovalenko, E.
    Kozhina, N.
    Zolotova, O.
    EUROPEAN HEART JOURNAL, 2014, 35 : 385 - 386
  • [2] Thrombocytes functional state and rheological characteristics of blood in patients with chronic heart failure due to coronary artery disease combined with chronic obstructive pulmonary disease
    Evdokimov, V.
    Kovalenko, E.
    Evdokimova, A.
    Voronina, G.
    Tebloev, K.
    EUROPEAN HEART JOURNAL, 2018, 39 : 375 - 375
  • [3] The phenotypes of chronic heart failure in patients with ischemic heart disease combined with chronic obstructive pulmonary disease
    Potabashniy, V. A.
    MEDICAL PERSPECTIVES-MEDICNI PERSPEKTIVI, 2018, 23 (03): : 161 - 171
  • [4] Clinical efficacy and safety of tiotropium and indacaterol administration in patient with chronic heart failure due to coronary artery disease combined with chronic obstructive pulmonary disease
    Evdokimov, VVladimir
    Evdokimova, A.
    Tebloev, K.
    Zolotova, O.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 251 - 251
  • [5] Clinical efficacy and safety of tiotropium and indacaterol administration in patient with chronic heart failure due to coronary artery disease combined with chronic obstructive pulmonary disease
    Evdokimov, V.
    Evdokimova, A.
    Kovalenko, E.
    Tebloev, K.
    Zolotova, O.
    EUROPEAN HEART JOURNAL, 2015, 36 : 664 - 664
  • [6] Clinical efficacy and safety of formoterol and tiotropium administration in patient with chronic heart failure due to coronary artery disease combined with chronic obstructive pulmonary disease
    Evdokimov, V. Vladimir
    Evdokimova, A.
    Sheyanov, M.
    Kozhina, N.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 68 - 68
  • [7] Prolonged use (18 months) of tiotropium and indacaterol in patient with chronic heart failure due to coronary artery disease combined with chronic obstructive pulmonary disease
    Evdokimov, V.
    Evdokimova, A.
    Kovalenko, E.
    Tebloev, K.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 369 - 369
  • [8] Osteopontin as a marker of pulmonary hypertension in patients with coronary heart disease combined with chronic obstructive pulmonary disease
    Hetman, O.
    Krakhmalova, O.
    CARDIOVASCULAR RESEARCH, 2016, 111 : S113 - S114
  • [9] Chronic Obstructive Pulmonary Disease and Heart Failure
    Villar Alvarez, Felipe
    Mendez Bailon, Manuel
    de Miguel Diez, Javier
    ARCHIVOS DE BRONCONEUMOLOGIA, 2009, 45 (08): : 387 - 393
  • [10] Heart Failure and Chronic Obstructive Pulmonary Disease
    Hawkins, Nathaniel M.
    Petrie, Mark C.
    MacDonald, Michael R.
    Jhund, Pardeep S.
    Fabbri, Leonardo M.
    Wikstrand, John
    McMurray, John J. V.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (21) : 2127 - 2138
12345